Mercados españoles cerrados en 1 hr 42 mins

AbbVie Inc. (ABBV)

NYSE - Nasdaq Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
148,29-0,77 (-0,52%)
A partir del 09:48AM EDT. Mercado abierto.

AbbVie Inc.

1 North Waukegan Road
North Chicago, IL 60064-6400
United States
847 932 7900
https://www.abbvie.com

Sector(es)Healthcare
SectorDrug Manufacturers—General
Empleados a tiempo completo50.000

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Richard A. GonzalezChairman & CEO6,95MN/A1954
Mr. Robert A. MichaelPres & COO4MN/A1970
Mr. Scott T. ReentsExec. VP & CFO2,97MN/A1968
Dr. Azita Saleki-Gerhardt Ph.D.Exec. VP & COO2,58MN/A1963
Mr. Jeffrey Ryan StewartExec. VP & Chief Commercial Officer2,98M2,78M1969
Dr. Thomas J. Hudson M.D.Sr. VP of R&D and Chief Scientific OfficerN/AN/A1962
Ms. Elizabeth SheaVP of Investor RelationsN/AN/AN/A
Ms. Tracie HaasSr. VP of Corp. Responsibility, Brand & CommunicationsN/AN/AN/A
Mr. Timothy J. RichmondExec. VP & Chief HR OfficerN/AN/A1966
Dr. Nicholas R. Donoghoe M.D.Exec. VP and Chief Bus. & Strategy OfficerN/AN/A1981
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Gobierno corporativo

El ISS Governance QualityScore de AbbVie Inc., a día 28 de septiembre de 2023, es 8. Las puntuaciones base son Auditoría: 10; Tablero: 4; Derechos de los accionistas: 9; Compensación: 6.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.